Comparison of secondary IgA nephropathy in patients with ankylosing spondylitis and rheumatoid arthritis

References

• Saha MK, Julian BA, Novak J, Rizk DV. Secondary IgA nephropathy. Kidney Int. 2018;94(4):674–81.
   PubMed Web of Science ®Google Scholar
• Couderc M, Tatar Z, Pereira B, Tiple A, Gilson M, Fautrel B, et al. Prevalence of renal impairment in patients with rheumatoid arthritis: results from a cross-sectional multicenter study. Arthritis Care Res (Hoboken). 2016;68(5):638–44.
   PubMed Web of Science ®Google Scholar
• Azevedo DC, Ferreira GA, Carvalho MA. IgA nephropathy in patients with spondyloarthritis followed-up at the Rheumatology Service of Hospital das Clínicas-UFMG. Rev Bras Reumatol. 2011;51(5):417–22.
   PubMedGoogle Scholar
• Lee SH, Lee EJ, Chung SW, Song R, Moon JY, Lee SH, et al. Renal involvement in ankylosing spondylitis: prevalence, pathology, response to TNF-a blocker. Rheumatol Int. 2013;33(7):1689–92.
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhang G, Wang N, Xue Q. Risk factors of renal involvement based on different manifestations in patients with ankylosing spondylitis. Kidney Blood Press Res. 2018;43(2):367–77.
   PubMed Web of Science ®Google Scholar
• Makino H, Yoshinaga Y, Yamasaki Y, Morita Y, Hashimoto H, Yamamura M. Renal involvement in rheumatoid arthritis analysis of renal biopsy specimens from 100 patients. Mod Rheumatol. 2002;12(2):148–54.
   PubMedGoogle Scholar
• Buttgereit F, da Silva JAP, Boers M, Burmester G-R, Cutolo M, Jacobs J, et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis. 2002;61(8):718–22.
   PubMed Web of Science ®Google Scholar
• Haas M, Verhave JC, Liu ZH, Alpers CE, Barratt J, Becker JU, et al. A multicenter study of the predictive value of crescents in IgA nephropathy. J Am Soc Nephrol. 2017;28(2):691–701.
   PubMed Web of Science ®Google Scholar
• Cattran DC, Coppo R, Cook HT, Feehally J, Roberts ISD, Troyanov S, et al. The oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76(5):534–45.
   PubMed Web of Science ®Google Scholar
• Huang X, Wu X, Le W, Hao Y, Wu J, Zeng C, et al. Renal prognosis and related risk factors for Henoch-Schönlein purpura nephritis: a Chinese Adult Patient Cohort. Sci Rep. 2018;8:5585.
   PubMed Web of Science ®Google Scholar
• Muthukumar P, Dhanapriya J, Gopalakrishnan N, Dineshkumar T, Sakthirajan R, Balasubramaniyan T. Evaluation of renal lesions and clinicopathologic correlation in rheumatoid arthritis. Saudi J Kidney Dis Transpl. 2017;28:44–50.
   PubMed Web of Science ®Google Scholar
• Vinicki JP, Pellet SC, De Rosa G, Dubinsky D, Laborde HA, Marini A, et al. Analysis of 65 renal biopsies from patients with rheumatoid arthritis (1976–2015): change in treatment strategies decreased frequency and modified histopathological findings. J Clin Rheumatol. 2015;21(7):335–40.
   PubMed Web of Science ®Google Scholar
• Montenegro V, Monteiro RC. Elevation of serum IgA in spondyloarthropathies and IgA nephropathy and its pathogenic role. Curr Opin Rheumatol. 1999;11(4):265–72.
   PubMedGoogle Scholar
• Hocini H, Iscaki S, Benlahrache C, Vitalis L, Chevalier X, Larget-Piet B, et al. Increased levels of serum IgA as IgA1 monomers in ankylosing spondylitis. Ann Rheum Dis. 1992;51(6):790–2.
   PubMed Web of Science ®Google Scholar
• Salas-Cuestas F, Bautista-Molano W, Bello-Gualtero JM, Arias I, Castillo DM, Chila-Moreno L, et al. Higher levels of secretory IgA are associated with low disease activity index in patients with reactive arthritis and undifferentiated spondyloarthritis. Front Immunol. 2017;8:476.
   PubMed Web of Science ®Google Scholar
• Derksen V, Huizinga TWJ, van der Woude D. The role of autoantibodies in the pathophysiology of rheumatoid arthritis. Semin Immunopathol. 2017;39(4):437–46.
   PubMed Web of Science ®Google Scholar
• Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1998;101(1):273–81.
   PubMed Web of Science ®Google Scholar
• Shi J, Knevel R, Suwannalai P, van der Linden MP, Janssen GM, van Veelen PA, et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci USA. 2011;108(42):17372–7.
   PubMed Web of Science ®Google Scholar
• Juarez M, Bang H, Hammar F, Reimer U, Dyke B, Sahbudin I, et al. Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis. Ann Rheum Dis. 2016;75(6):1099–107.
   PubMed Web of Science ®Google Scholar
• Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376(9746):1094–108.
   PubMed Web of Science ®Google Scholar
• Derksen VF, Ajeganova S, Trouw LA, van der Helm-van Mil AH, Hafstrom I, Huizinga TW, et al. Rheumatoid arthritis phenotype at presentation differs depending on the number of autoantibodies present. Ann Rheum Dis. 2017;76(4):716–20.
   PubMed Web of Science ®Google Scholar
• Quaden DHF, De Winter LM, Somers V. Detection of novel diagnostic antibodies in ankylosing spondylitis: an overview. Autoimmun Rev. 2016;15(8):820–32.
   PubMed Web of Science ®Google Scholar
• Madden DR. The three-dimensional structure of peptide–MHC complexes. Annu Rev Immunol. 1995;13:587–622.
   PubMed Web of Science ®Google Scholar
• Faham M, Carlton V, Moorhead M, Zheng J, Klinger M, Pepin F, et al. Discovery of T-cell receptor beta motifs specific to HLA-B27+ ankylosing spondylitis by deep repertoire sequence analysis. Arthritis Rheumatol. 2017;69(4):774–84.
   PubMed Web of Science ®Google Scholar
• Rysnik O, McHugh K, van Duivenvoorde L, van Tok M, Guggino G, Taurog J, et al. Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue. J Autoimmun. 2016;70:12–21.
   PubMed Web of Science ®Google Scholar
• Ridley A, Hatano H, Wong-Baeza I, Shaw J, Matthews KK, Al-Mossawi H, et al. Activation-induced killer cell immunoglobulin-like receptor 3DL2 binding to HLA-B27 licenses pathogenic T cell differentiation in spondyloarthritis. Arthritis Rheumatol. 2016;68(4):901–14.
   PubMed Web of Science ®Google Scholar
• Vanaki N, Aslani S, Jamshidi A, Mahmoudi M. Role of innate immune system in the pathogenesis of ankylosing spondylitis. Biomed Pharmacother. 2018;105:130–43.
   PubMed Web of Science ®Google Scholar
• Klareskog L, Widhe M, Hermansson M, Rönnelid J. Antibodies to citrullinated proteins in arthritis: pathology and promise. Curr Opin Rheumatol. 2008;20(3):300–5.
   PubMed Web of Science ®Google Scholar
• Vencovský J, Machácek S, Sedová L, Kafková J, Gatterová J, Pesáková V, et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis. 2003;62(5):427–30.
   PubMed Web of Science ®Google Scholar
• Forslind K, Ahlmén M, Eberhardt K, Hafström I, Svensson B, BARFOT Study Group. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis. 2004;63(9):1090–5.
   PubMed Web of Science ®Google Scholar
• Rönnelid J, Wick MC, Lampa J, Lindblad S, Nordmark B, Klareskog L, et al. Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis. 2005;64(12):1744–9.
   PubMed Web of Science ®Google Scholar
• Kastbom A, Strandberg G, Lindroos ATS. Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis. 2004;63(9):1085.
   PubMed Web of Science ®Google Scholar
• Watad A, Amital H. ACPAs are much more than diagnostic autoantibodies. Rambam Maimonides Med J. 2016;7(4):e0028.
   Web of Science ®Google Scholar
• Nakken B, Papp G, Bosnes V, Zeher M, Nagy G, Szodoray P. Biomarkers for rheumatoid arthritis: from molecular processes to diagnostic applications—current concepts and future perspectives. Immunol Lett. 2017;189:13–8.
   PubMed Web of Science ®Google Scholar
• Nakano M, Ueno M, Nishi S, Suzuki S, Hasegawa H, Watanabe T, et al. Determination of IgA- and IgM-rheumatoid factors in patients with rheumatoid arthritis with and without nephropathy. Ann Rheum Dis. 1996;55(8):520–4.
   PubMed Web of Science ®Google Scholar
• Vincent C, Nogueira L, Sebbag M, Chapuy-Regaud S, Arnaud M, Letourneur O. Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: a highly effective test for the diagnosis of rheumatoid arthritis. Arthritis Rheum. 2002;46(8):2051.
   PubMedGoogle Scholar
• Cheng TT, Yu SF, Su FM, Chen YC, Su BY, Chiu WC, et al. Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX®: a registry study of RA with osteoporosis/fracture. Arthritis Res Ther. 2018;20(1):16.
   PubMedGoogle Scholar
• Couderc M, Pereira B, Molto A, Tiple A, Soubrier M, Dougados M. The prevalence of renal impairment in patients with spondyloarthritis: results from the international ASAS-COMOSPA study. J Rheumatol. 2018;45(6):795–801.
   PubMed Web of Science ®Google Scholar